Latest filing published 07 Aug 2026 for Merck & Co., Inc., €514k.
This profile gathers the share dealings of David Michael Williams in Merck & Co., Inc., where the filings describe the role as senior executive. We count 41 filings; the first trade dates from 10 February 2021 and the latest from 5 August 2026.
On the market, this insider has only sold: 8 sales, €8.5M in total. The rest of the record consists of 17 share grants and 16 option exercises. Since January 2026: no purchases and 4 sales on the market.
The record was last updated on 7 August 2026 with an open-market sale (€514k) in Merck & Co., Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations